The Modified Glasgow Outcome Score for the prediction of outcome in patients after cardiac arrest: a prospective clinical proof of concept study
- 10 February 2012
- journal article
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 101 (7) , 533-543
- https://doi.org/10.1007/s00392-012-0423-7
Abstract
The Glasgow–Pittsburgh cerebral performance categories (GP-CPC) and the Glasgow Outcome Score (GOS) have been used to categorize patients according to their neurological outcome for prognostic predictors in patients after cardiac arrest (CA). We postulated that inclusion of deaths without knowing the cerebral status into the group of patients with poor outcome after CA using the GP-CPC and GOS will lead to dilution of the prognostic power of the investigated biochemical marker. The present study was conducted to verify this issue by employing a modified outcome score, which we termed as Modified Glasgow Outcome Score (MGOS). In the present study, 97 patients were enrolled in a prospective manner. Serum NSE and S100B levels were measured daily for 7 days after admission to the intensive care unit. Neurological outcome was assessed by employing the GOS and MGOS after 6 months. By employing the GOS, 46 patients were categorized into the group of patients with poor outcome and 51 patients survived with good neurological outcome. Patients who died without certified brain damage or with unknown cerebral status after CA (n = 20) were separated from patients with poor outcome in the MGOS. The magnitude of NSE (S100B) elevation in patients with poor outcome categorized by the MGOS was approximately 1.7-fold (1.5) higher as compared with patients divided by the GOS. The mean calculated sensitivities and area under the curve values of NSE and S100B predicting poor outcome classified by the MGOS were significantly higher as compared with the GOS. Conclusively, inclusion of deaths without certified brain damage or with unknown cerebral status into the group of patients with poor outcome will lead to underestimation of the prognostic power of investigated biochemical markers such as NSE and S100B. The MGOS will help to avoid this bias.Keywords
This publication has 21 references indexed in Scilit:
- Coronary angiography and intervention during hypothermia can be performed safely without cardiac arrhythmia or vasospasmClinical Research in Cardiology, 2011
- Biochemical markers and somatosensory evoked potentials in patients after cardiac arrest: The role of neurological outcome scoresJournal of the Neurological Sciences, 2011
- Autonomic regulation during mild therapeutic hypothermia in cardiopulmonary resuscitated patientsClinical Research in Cardiology, 2011
- Effects of mild hypothermia on hemodynamics in cardiac arrest survivors and isolated failing human myocardiumClinical Research in Cardiology, 2010
- Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitationResuscitation, 2009
- Serum S-100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitationResuscitation, 2009
- Practice Parameter: Prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review) [RETIRED]Neurology, 2006
- Prediction of neurological outcome after cardiopulmonary resuscitation by serial determination of serum neuron-specific enolaseEuropean Heart Journal, 2006
- Serum Neuron-Specific Enolase and S-100B Protein in Cardiac Arrest Patients Treated With HypothermiaStroke, 2003
- Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council.Circulation, 1991